The Shanghai-based conglomerate with a wide array of activities such as pharmaceuticals or healthcare, being present on the global front through its 7.1% stake in Club Med, generates an annual revenue of 4.5 billion euros and has perfectly aligned its strategy to answer Chinese population's social needs (such as ageing population or new consumption habits).